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Pancreatic stellate cells (PSCs) play a key role in the dense desmoplastic stroma associated with
pancreatic ductal adenocarcinoma. Studies on human PSCs have been minimal due to difﬁculty in
maintaining primary PSC in culture. We have generated the ﬁrst conditionally immortalized
human non-tumor (NPSC) and tumor-derived (TPSC) pancreatic stellate cells via transformation
with the temperature-sensitive SV40 large T antigen and human telomerase (hTERT). These cells
proliferate at 331C. After transfer to 371C, the SV40LT is switched off and the cells regain their
primary PSC phenotype and growth characteristics. NPSC contained cytoplasmic vitamin
A-storing lipid droplets, while both NPSC and TPSC expressed the characteristic markers αSMA,
vimentin, desmin and GFAP. Proteome array analysis revealed that of the 55 evaluated proteins,
27 (49%) were upregulated Z3-fold in TPSC compared to NPSC, including uPA, pentraxin-3,
endoglin and endothelin-1. Two insulin-like growth factor binding proteins (IGFBPs) were
inversely expressed. Although discordant IGFBP-2 and IGFBP-3 levels, IGF-I was found to
stimulate proliferation of both NPSC and TPSC. Both basal and IGF-I stimulated motility was
signiﬁcantly enhanced in TPSC compared to NPSC. In conclusion, these cells provide a unique
resource that will facilitate further study of the active stroma compartment associated with
pancreatic cancer.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).lsevier Inc. This is an open access article under the CC BY-NC-SA license
3.0/).
NPSC, non-tumor derived pancreatic stellate cell; TPSC, tumor-derived pancreatic stellate
A, alpha smooth muscle actin; ECM, extra cellular matrix; IGF, insulin-like growth factor;
tein; ITS, insulin-transferrin-selenium
and Skåne University Hospital, Department Clinical Sciences Lund, Division of Oncology and
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Pancreatic ductal adenocarcinoma is a highly malignant tumor
with the highest death rate among all cancers. As this cancer
shows no symptoms in its early stages it has a low probability of
detection, and the majority (485%) of pancreatic cancer patients
already have locally advanced disease or metastases at time of
initial diagnosis making them unsuitable for surgical treatment [1].
In addition, pancreatic cancer is resistant to chemotherapy and
currently available treatments provide only marginal survival ben-
eﬁts. The characteristic dense stroma surrounding the tumor cells is
believed to promote tumor survival and resistance to treatment by
creating a physical barrier and block drug distribution [2,3].
Although being a central pathological feature of pancreatic cancer,
the cellular and molecular interactions underlying the stroma
reaction remain incompletely understood.
Pancreatic stellate cells (PSCs) are myoﬁbroblast-like cells and
the key ﬁbrogenic cell type of the pancreas. They are believed to
be the source of the stromal reaction associated with pancreatic
cancer [4]. PSCs are normally found in an inactive, quiescent state
in the healthy pancreas, where they maintain normal pancreatic
architecture. Quiescent PSCs can be identiﬁed by the presence
of cytoplasmic retinoid (vitamin A)-storing lipid droplets
and expression of intermediate ﬁlaments and mesenchymal
markers such as vimentin, desmin and glial ﬁbrillary acidic
protein (GFAP) [5,6]. During local inﬂammation or pancreatic
cancer, the PSCs transform from a quiescent to an active state,
leading to loss of cytoplasmic vitamin A-storing lipid droplets,
increased expression of alpha smooth muscle actin (αSMA) and
induction of a number of factors such as PDGF, TGF-β, IL-6 and
others that contribute to the aggressive growth of pancreatic cancer
[7]. Activated PSCs have also been suggested to play an important
role in development of pancreatic cancer metastases by facilitating
migration, extracellular matrix (ECM) deposition and remodeling.
Until recently, studies on human PSCs have been minimal due to
limited availability of fresh resected pancreatic specimens, as well as
difﬁculties in isolating and culturing these cells in the laboratory
environment. Once isolated, the primary PSCs undergo senescence
within a limited number of passages, making it difﬁcult to obtain
sufﬁcient cell quantities for functional studies [8]. To overcome the
limited availability, other laboratories have previously developed
immortalized cell lines from human PSCs that unlike the primary
cells, divide at a fast rate in the laboratory [9,8]. These cell lines
rapidly generate enough cells to study. However, their fast growth
rate and continuous proliferation do not accurately represent the
primary cell phenotype.
The aim of the present study was to develop exclusively unique
and highly relevant cell lines from human normal non-tumor
(NPSC) and tumor-derived (TPSC) pancreatic stellate cells. For this
purpose, we have generated the ﬁrst conditionally immortalized
human pancreatic stellate cell lines by infection with the
temperature-sensitive SV40LT gene and telomerase. This technol-
ogy has been successfully applied previously in cultured human
mammary ﬁbroblasts, podocytes, glomerular endothelial and
mesangial cells [10–13]. These cells rapidly divide and grow at
the “permissive” temperature (331C). After transfer to the “non-
permissive” temperature (371C), the SV40LT gene is switched off
and the cells regain their primary PSC phenotype and growth rate.
Using these cell lines we sought to identify NPSC and TPSCphenotype characteristics at the protein level and to elucidate
their functional responses to insulin-like growth factor-I (IGF-I)
on growth and migratory capabilities.Materials and methods
Primary culture of pancreatic stellate cells
Non-neoplastic and neoplastic pancreatic specimens were
obtained from a patient with moderately differentiated pancreatic
ductal adenocarcinoma and new onset type-2-diabetes under-
going primary surgical resection. This study was approved by the
regional ethical review board in Lund, Sweden. Isolated pancreatic
stellate cells from adjacent safe margin specimen were considered
to be normal. Pancreatic stellate cells were isolated by the
outgrowth method as described previously [6] and cultured in
25-cm2 ﬂasks in DMEM/Hams Nutrient Mix F12 (Invitrogen,
Paisley, UK) medium with added antibiotics (100 U/ml penicillin
and 100 mg/ml streptomycin; Invitrogen), 1% Amphotericin-B
(Sigma-Aldrich, St. Louis, Mo, USA), 2 mM L-glutamine (Sigma-
Aldrich) and 10% FBS (Invitrogen) in a humidiﬁed 5% CO2 atmo-
sphere at 371C. Pancreatic stellate cell outgrowths appeared at
7–14 d, and allowed to reach 80% conﬂuence before the cells were
passaged and transfected with the tsSV40LT gene and hTERT
constructs.Conditional immortalization – retroviral constructs and
virus infection
A packaging cell line producing a bicistronic construct contain-
ing a temperature-sensitive simian virus-40 large T-antigen
(tsSV40LT) and human telomerase (hTERT) as described pre-
viously was used [10]. Brieﬂy, cultures of primary human non-
tumor or tumor-derived PSCs (at passage 3) were infected with
retrovirus-containing supernatants from the packaging cell line
(tsTTERT C126). Midconﬂuent cells in log-phase growth were
exposed to freshly thawed ﬁltered (0.45 mm) supernatant mixed
7:3 with growth medium and 10 mg/ml polybrene (Sigma-
Aldrich). After 24 h, cultures were replaced with normal growth
medium and the cells were allowed to reach conﬂuence at 371C.
The culture medium was then supplemented with 0.5 mg/ml
G418 (Life Technologies BRL, Paisley, UK) until selection was
completed (14 days). Selection and continuous culture were
carried out at 331C. After 2 weeks clones of healthy selected cells
began to appear. Surviving cells were allowed to approach
conﬂuence in standard medium. Subcloning by limited dilution
was achieved by seeding cells in 96-well plates at a density of 1
cell/well. Approximately 10 clones of each cell line were further
characterized based on the greatest similarity to the primary cells
and subjected to a second round of subcloning and characteriza-
tion. Conditionally immortalized PSCs were growth in RPMI 1640
medium supplemented with antibiotics (100 U/ml penicillin and
100 mg/ml streptomycin; Invitrogen), ITS (Sigma-Aldrich) and 10%
FBS (GIBCO). Cells were grown to 80% conﬂuence before thermo-
switching to 371C. At both temperatures, cells were fed with fresh
medium three times per week.
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Biopsies of residual tissues used for PSC isolation were ﬁxed,
parafﬁn embedded, sectioned 4 mm and routinely processed for
Martius scarlet blue staining (MSB). Collagen and connective
tissue are visualized in blue, while ﬁbrin and zymogen granules
are stained in bright red.
Oil Red-O staining
Cells were cultured (3104 cells/well) in four-well chamber
slides (Lab-Tek II Chamber Slide System, Nunc), ﬁxed in 2%
paraformaldehyde followed by Oil Red-O staining for cytoplasmic
vitamin A storing lipid droplets. Intracellular lipid droplets were
examined by light microscopy using a Nikon Eclipse 80i micro-
scope with Nikon DS-Qi1 camera and NIS-Elements software.
Immunoﬂuorescence
Cells cultured (10103 cells/well) in eight-well chamber slides
(Lab-Tek II Chamber Slide System, Nunc) were ﬁxed in 2%
paraformaldehyde, permeabilized in 1% Triton X-100, blocked
(5% donkey serum and 1% Triton X-100) followed by immuno-
ﬂuorescent staining for α-SMA, vimentin, desmin and GFAP at 41C
overnight. Following washing, secondary antibodies (Invitrogen)
donkey-anti-goat (Alexa ﬂuor 488) or donkey-anti-mouse (Alexa
ﬂuor 488) were added for 1 h at room temperature and nuclei/
DNA counterstained with DAPI. Positive staining was analyzed
using a Nikon Eclipse 80i microscope with a Nikon DS-Qi1 camera
and NIS-Elements software.
Western immunoblotting
Cells were lysed and processed as described previously [14].
Lysates were loaded according to protein concentration, separated
(65 μg protein per lane) by SDS-PAGE (12%) and transferred to
0.2 μm Hybond-C extra nitrocellulose membrane (Amersham
Biosciences). The blocked membranes were probed overnight
(41C) with the following antibodies: anti-SV40LT (BD Pharmingen
PAb101; 1:1000), anti-vimentin (R&D Systems AF2105; 1:500),
anti-α-SMA (DAKO M0851; 1:2000), anti-desmin (R&D Systems
AF3844; 1:500), anti-GFAP (SigmaAldrich G-A-5; 1:1000) and
anti-GAPDH (Millipore MAB374; 1:1000). Subsequently, the mem-
branes were incubated with horseradish peroxidase (HRP)-con-
jugated secondary antibody and visualized by SuperSignal West
Dura Substrate (PIERCE, ThermoScientiﬁc) using LI-COR Odyssey
Fc imaging system and Image Studio software (LI-COR Biosciences
Ltd, Cambridge, UK).
Cell cycle analysis
Primary or conditionally immortalized NPSC and TPSC were
seeded in ﬂasks at subconﬂuent density, placed at either 331C
or 371C. Cells were harvested, ﬁxed in ice cold 70% ethanol,
stained with PI/RNAse buffer (BD Biosciences, San Diego, CA), and
subjected to cell cycle analysis (FL2-A) on a FACSCalibur ﬂow
cytometer (BD Biosciences) with CellQuest Pro software (BD
Biosciences). Approximately 2105 events (cells) were evaluated
for each sample using FlowJo Vx software (Tree Star Inc, Ashland,
OR, USA).Proteome proﬁler array
Proteins were extracted from cultured NPSC and TPSC and
concentration determined as above. Equal amounts of protein
were evaluated using the Proteome Proﬁler™ Human Angiogen-
esis Array, according to the manufacturer's instructions (R&D
Systems) and visualized by SuperSignal West Dura Substrate
(PIERCE, ThermoFisherScientiﬁc) using the LI-COR Odyssey Fc
imaging system and Image Studio software (LI-COR Biosciences
Ltd, Cambridge, UK). Relative levels of protein expression were
quantiﬁed by analyzing the average pixel density after back-
ground correction. Heat map of fold difference in relative protein
abundance was generated by comparing the pixel densities
(normalized to internal assay controls) of the corresponding
signals between NPSC and TPSC at 371C.
Cell proliferation
Cells were seeded (10103 cell/well) in 96-well plates in growth
media for 24 h before switching to serum-free media (SFM) for a
further 24 h. Cells were subsequently dosed with IGF-I (100 ng/
ml) in SFM in quadruplicate (n¼4 wells). Following incubation for
24 h, the cell proliferation was assessed by tetrazolium dye [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide]
(MTT; Cell Proliferation Kit I) assay according to the manufac-
turer's instructions (R&D Systems). The samples were measured
on a Labsystems Multiskan Plus plate reader (test wavelength
595 nm, reference wavelength 660 nm) using the DeltaSoft JV
software (BioMetallics Inc., Princeton, NJ, USA). Cell proliferation
in the time-course experiments of SV40LT silencing after thermo-
switching was determined by cell counting using trypan blue dye
exclusion.
Invasion and motility assays
The invasion assay was performed using Transwell cell culture
inserts (24 wells, 8-μm pore size; BD Biosciences). Brieﬂy, 5104
NPSC or TPSC cells in 300 ml SFM were added to the culture
inserts upper chamber. SFM with or without IGF-I (100 ng/ml)
was added to the lower chamber. After 24 h, the non-invading
cells on the upper surface of the insert membrane were removed
using cotton swabs. Invaded cells were ﬁxed in 1% glutaraldehyde,
stained with 0.5% crystal violet for 30 min and counted at 10
magniﬁcation in four different microscopic ﬁelds for each insert.
The experiments were repeated at least three times. Additionally,
TPSC motility was assayed using scratch assay. TPSCs were seeded
at conﬂuence in four-well chamber slides in growth media for
24 h before switching to SFM for a further 24 h. Wounds were
made using sterile white pipette tips prior to dosing as above.
Following 16 h migration, the cells were ﬁxed in 2% paraformal-
dehyde, permeabilized in 1% Triton X-100 and exposed to Alexa
Fluor 488-conjugated phalloidin (Life Technologies) and DAPI to
visualize F-actin cytoskeleton and nuclei, respectively.
Statistical analysis
The data were presented as means7SE. Statistical analyses were
performed using two-tailed Student's t-test. A P-value of o0.05
was considered statistically signiﬁcant.
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Cell culture and vitamin A-storing lipid droplet abundance
Primary human PSCs were isolated from residual normal and
pancreatic cancer surgical specimens. MSB staining of the tissues
veriﬁed a normal pancreatic histology and a moderately differ-
entiated tumor with highly abundant stroma in blue (Fig. 1A).
Conditionally immortalized human non-tumor (NPSC) and tumor-
derived (TPSC) pancreatic stellate cell lines were developed by
restoring functional telomerase activity and introducing the
temperature-sensitive SV40T gene. These cells demonstrated
enhanced proliferation at the permissive temperature 331C, while
after transfer to the nonpermissive temperature 371C they
regained a low proliferation rate. PSCs were used in experiments
after at least 6 days at 371C. The PSCs were validated for the
presence of cytoplasmic vitamin A-containing lipid droplets.
Primary NPSC displayed multiple cytoplasmic lipid droplets,
characteristic of a quiescent state (Fig. 1B). Actively proliferating
conditionally immortalized NPSCs had reduced cell bodies with
less lipid droplets. Post-thermoswitching, the morphology and
lipid droplet abundance appeared similar to the primary parental
cells indicating a quiescent NPSC phenotype. In contrast, bothFig. 1 – Morphology and activation status of cultured NPSC and TPS
pancreatic tissue and pancreatic ductal adenocarcinoma with mass
lipid droplets of primary and conditionally immortalized NPSC and
high abundance of characteristic lipid droplets in primary and imm
cytoplasmic expression of lipid droplets in primary and immortaliprimary and conditionally immortalized TPSCs displayed signiﬁ-
cantly less cytoplasmic lipid droplets indicative of an active state
(Fig. 1B).Verifying the expression of PSC markers in cultured PSCs
In culture, PSCs resemble activated myoﬁbroblasts, expressing a
variety of mesenchymal and myoﬁbroblast-associated proteins. To
conﬁrm the phenotype of the conditionally immortalized NPSC
and TPSC, a combination of characteristic cell markers were
examined by immunoﬂuorescence and Western blot. The inter-
mediate ﬁlament and general mesenchymal marker vimentin, as
well as the principle actin isoform associated with myoﬁbroblasts
α-SMA, were strongly expressed in a linear pattern in the
cytoplasm of both NPSC and TPSC (Fig. 2A). Additional inter-
mediate ﬁlaments, desmin and glial ﬁbrillary acidic protein
(GFAP) were also expressed in PSCs. The immunostaining results
were supported by Western blot conﬁrming the expression of PSC
cell markers α-SMA, vimentin, desmin and GFAP (Fig. 2B). Densi-
tometry quantiﬁcation revealed higher α-SMA, vimentin and
desmin abundance post-thermoswitching compared to the
actively proliferating state at 331C (Fig. 2B).C at 331C and 371C. (A) Martius scarlet blue staining of normal
ive stroma in blue. (B) Oil Red-O staining of vitamin-A storing
TPSC at 331C and after 7 days at 371C. Images demonstrating a
ortalized NPSC indicative of a quiescent phenotype. The weak
zed TPSC, indicate a more active phenotype. Scale bars¼50 μm.
Fig. 2 – Expression of characteristic pancreatic stellate cell markers in conditionally immortalized NPSC and TPSC at 331C and after
7 days at 371C. (A) Immunoﬂuorescent staining of αSMA, vimentin, desmin and GFAP. Scale bars¼50 μm. (B) Western blotting analyses
conﬁrming the expression of pancreatic stellate cell speciﬁc markers. GAPDH is shown as a loading control. One representative blot of
three independent experiments is shown. Relative protein abundance was quantiﬁed by densitometry analysis and corrected for
GAPDH. The graphs show modulation of relative protein abundance at 371C versus 331C and represent the mean7SE.
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Fig. 3 – Silencing of tsSV40LT after thermoswitching of NPSC and TPSC. Time-course analysis of tsSV40LT protein expression in
(A) NPSC and (B) TPSC at 331C (day 0) and at 371C (days 1–5). Western immunoblot and densitometry analysis shows a rapid decline in
SV40LT expression after the transfer to nonpermissive temperature 371C. GAPDH was used as a loading control. Cell proliferation
analyzed by cell counting showed a signiﬁcant declining growth rate of (C) NPSC and (D) TPSC after thermoswitching to 371C. Data
is shown as percent growth compared to control cells at 331C. Graphs represent mean7SE of three independent experiments.
*Po0.05, **Po0.01, ***Po0.001.
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Western blotting conﬁrmed the successful transformation and
expression of SV40LT in both NPSC (Fig. 3A) and TPSC (Fig. 3B) at
331C where the antigen is active and allowing enhanced cell
proliferation. Time-course analysis showed a rapid silencing of the
tsSV40LT antigen after thermoswitching the cells to 371C (Fig. 3A,B).
The SV40LT silencing was reﬂected in the reduced growth rate
observed over time in both NPSC (Fig. 3C) and TPSC (Fig. 3D).
Cell cycle distribution
Cell cycle distribution was compared between primary TPSC and
conditionally immortalized NPSC and TPSC grown at 331C and 371C.
Insufﬁcient cell quantities prohibited cell cycle analysis of primary
NPSCs. Primary TPSCs showed a very low level of proliferation with
more than 80% of the cells in G0/G1 phase, while only 3.4% were
found in DNA synthesis (S-) phase and 6.8% growing and actively
dividing in G2/M phase (Fig. 4A,B). Conditionally immortalized TPSCs
grown at the permissive temperature 331C proliferated rapidly with
approximately 10% in S-phase and 21% in G2/M phase, while only 68%
were in G0/G1 phase. Importantly, after 5 days at 371C and the
tsSV40LT switched off, the conditionally immortalized TPSCsdemonstrated high resemblance to primary TPSCs, with a detectable,
but low level of proliferation. A similar cell cycle distribution was
observed for NPSC when grown under these conditions (Fig. 4A,B).
Proteome proﬁler array
To further characterize the conditionally immortalized PSCs, a panel
of 55 different proteins was evaluated by proteome proﬁler array
comparing NPSC and TPSC at both the permissive and non-
permissive temperatures. Overall the expression patterns were
similar between the permissive and non-permissive temperatures,
in both NPSC and TPSC (Fig. 5A). However, several differences in the
expression pattern were observed between NPSC and TPSC (Fig. 5B).
Among the 55 evaluated proteins, 37 were upregulated Z2-fold,
and 27 were upregulated Z3-fold in TPSC compared to NPSC. In
contrast, only 4 proteins were upregulated Z2-fold in NPSC
compared to TPSC. Several proteins involved in angiogenesis regula-
tion and matrix remodeling (tissue factor, thrombospondin-1, plas-
minogen activator inhibitor-1, tissue inhibitor of matrix
metalloproteinases-1, ﬁbroblast growth factor-1 and -2) were among
the abundantly expressed proteins. Among the top differentially
expressed and elevated proteins in TPSC were urokinase plasmino-
gen activator (uPA, P¼0.033), pentraxin 3 (PTX3, P¼0.0047),
Fig. 4 – Cell cycle distribution of primary TPSC and conditionally immortalized NPSC and TPSC. (A) Cell cycle histograms of
conditionally immortalized NPSC and TPSC at the growth-permissive (331C) and non-permissive (371C, 5 days) temperatures,
relative to primary TPSC. (B) Flow cytometry evaluation of cell cycle distribution (%) of conditionally immortalized NPSC and TPSCs
at 331C (day 0) and at 371C (days 1–5) versus primary TPSCs. Data is shown as meanþSE of three individual repeats for conditionally
immortalized NPSC and TPSC, and for one repeat of primary TPSC due to the limited availability of primary cells.
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endoglin (P¼0.055) and endothelin-1 (P¼0.026). In contrast, IL-1β
(P¼0.024) and CCL-2 (MCP-1, P¼0.029) were reduced in TPSC
compared to NPSC. Interestingly, the two IGFBPs -2 and -3 were
inversely expressed with IGFBP-2 predominantly expressed in TPSC
(6.6-fold enhanced, P¼0.012), while IGFBP-3 was primarily
expressed in NPSC (6.7-fold enhanced, P¼0.0048).
IGF-I stimulates proliferation and motility of pancreatic
stellate cells.
Following the observation that the IGFBP-2 and IGFBP-3 were
inversely expressed in NPSCs and TPSC, we evaluated the respon-
siveness to IGF-I stimulation on PSC proliferation and migration.
Exposure to IGF-I for 24 h increased the proliferation of NPSC by 33%
(Po0.01) and TPSC by 50% (Po0.001) compared with controls
(Fig. 6A). IGF-I also increased PSC motility and invasion, as measuredby scratch and Transwell assays (Fig. 6B–D). The presence of IGF-I
enhanced TPSC invasion by 3.6-fold (Po0.001) compared to basal,
while enhancing NPSC invasion by 2.6-fold (Po0.01). Notably, TPSC
showed a signiﬁcantly increased basal (9.2-fold, Po0.001) and IGF-I-
stimulated (12.4-fold, Po0.001) motility compared to NPSC (Fig. 6B,
C). The TPSC motility displayed an organized, ray-like pattern with all
migrating TPSCs demonstrating a dense lamellipodium network with
protrusions at the leading edge, as visualized by phalloidin staining of
F-actin cytoskeleton in a scratch assay (Figs. 6D,E). These results
demonstrate that both basal and IGF-I-stimulated motility of TPSC
were signiﬁcantly enhanced compared to NPSC.Discussion
Pancreatic cancer is associated with a highly abundant stroma.
The tumor microenvironment and pancreatic stellate cells in
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ness of this disease. However, previously studies on pancreatic
stellate cells have been minimal due to difﬁculty of maintaining
primary human pancreatic stellate cells in culture for a long time,thus limiting experiments with sufﬁcient replicates. Our study is
the ﬁrst to report the generation of conditionally immortalized
human non-tumor and tumor-derived pancreatic stellate cell
lines. These cells will provide a highly signiﬁcant and unique
resource for further study of human PSCs and their role in
pancreatic cancer progression, local inﬂammation and response
to treatments.
Other laboratories have established human pancreatic stellate
cell lines immortalized with SV40LT, which continuously prolif-
erate and can be grown for prolonged time [9,8]. However,
previously established PSC lines have been generated without
the ability to switch off SV40LT. The use of a temperature-
sensitive SV40LT allows unlimited replication at the permissive
temperature, while transfer to the non-permissive temperature
371C switches off SV40 allowing the cells to regain their native
characteristics with minimal interference with the primary cell
phenotype. As primary stellate cells grow slowly, the conditional
immortalization will provide a highly relevant and representative
cell model.
Actively proliferating conditionally immortalized NPSCs and
TPSCs displayed reduced cell bodies at the growth permissive
temperature. In contrast, post-thermoswiching, the morphology
appearance was different and the cells regained a larger stellate
cell shape, similar to the primary parental PSCs. This change in
morphology is consistent with a reduced growth rate of cultured
PSCs and a shift toward the G1 phase of the cell cycle [15]. The
conditionally immortalized cells expressed high levels of
tsSV40LT at the growth-permissive temperature allowing them
to proliferate. However, the SV40LT levels were rapidly reduced
following transfer of the cells to the non-permissive temperature.
After 5 days at 371C, the immortalized stellate cells showed
equivalent cell cycle distribution and phenotypic characteristics
of primary stellate cells in culture. Both NPSC and TPSC were
positive for the characteristic markers vimentin, desmin, GFAP
and αSMA. Notably, the NPSCs had considerably higher levels of
cytoplasmic lipid droplets compared to TPSCs. Vitamin A-storing
lipid droplets are associated with a quiescent state of PSCs and are
described as one of the major distinguishing features between
normal resident PSCs and activated tumor-associated PSCs [16].
To further establish the phenotype of the immortalized cells we
compared the protein proﬁles between NPSC and TPSCs. PSCs play
important roles in the local tumor microenvironment by regulat-
ing ECM composition and negatively inﬂuence angiogenesis [17].
Indeed, we found the PSCs to express several novel as well as
previously reported proteins involved in matrix remodeling
(urokinase plasminogen activator; uPA, matrix metalloprotei-
nases; MMPs, and plasminogen activator inhibitor-1; PAI-1) and
suppressing angiogenesis (endostatin, angiostatin and thrombos-
pondin). Among the 55 evaluated proteins, 37 were upregulatedFig. 5 – Protein expression by proteome proﬁler array of NPSC
and TPSC. (A) The protein expression patterns were similar
between the permissive (331C) and non-permissive (371C)
temperatures, in both NPSC and TPSC. (B) Relative levels of the
analyzed proteins, quantiﬁed by densitometry and shown in a
heat map to illustrate differential levels between NPSC and
TPSC at 371C. Colored bar indicate fold difference (green,
enhanced; red, reduced) between TPSC and NPSC protein levels
(n¼2). (n)P¼0.055, *Po0.05, **Po0.01.
Fig. 6 – Pancreatic stellate cell responsiveness to growth factors. (A) NPSC and TPSC were exposed to IGF-I (100 ng/ml) for 24 h and
cell proliferation analyzed by MTT. Data represent mean7SE of four replicate wells from one out of three individual experiments.
(B, C) Invasive capabilities of NPSC and TPSC after 24 h transwell invasion with IGF-I (100 ng/ml) or SFM control added to the lower
chamber. (B) Representative images from one of three independent experiments are shown. Scale bars¼100 lm. (C) Graph
represents number of invaded cells as mean7SE in four ﬁelds for each insert (magniﬁcation 10 ). Both basal and IGF-I-induced
invasion was signiﬁcantly higher in TPSC compared to NPSC. (D) Basal and IGF-I-stimulated motility of TPSC after 16 h migration in
a scratch assay. Scale bars¼100 μm. (D, E) F-actin cytoskeleton is visualized in green and nuclei by DAPI staining in blue. (E) White
arrow indicates the dense lamellipodium network with protrusions at the leading edge of IGF-I stimulated TPSC. Scale bar¼10 μm.
**Po0.01, ***Po0.001, Student's t-test.
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lated protein and 12-fold enhanced in TPSC compared to NPSC.
uPA is known to modulate cell adhesion and enhance both cell
proliferation and migration of many tumors. Ampliﬁcation of the
uPA receptor gene, thus rendering tumors more sensitive to uPA,
has been implicated in pancreatic cancer progression [18].
The membrane glycoprotein endoglin and the vasoconstricting
peptide endothelin-1 were also among the top differently
expressed proteins, both enhanced 46-fold in TPSC relative to
NPSC. Endoglin is part of the TGF-β receptor complex and
modulates TGF-β responses [19]. The enhanced endoglin expres-
sion by TPSC may contribute to increased responsiveness to pro-
ﬁbrotic stimuli by TGF-β and thus promote the excessive ﬁbrotic
process in the pancreatic tumor stroma, as previously shown formurine hepatic stellate cells [20]. Furthermore, endoglin contains
an RGD-sequence that enables cell adhesion via interaction with
integrin receptors and ECM components such as ﬁbronectin [21].
Endothelin-1 has previously been reported to be expressed by
primary rat PSC and to stimulate their contraction and migration
[22]. The elevated levels of endoglin and endothelin-1 by TPSC
may thus contribute to the more motile cell phenotype compared
to NPSC.
In addition to their matrix and angiogenesis regulating roles,
the tumor-associated PSCs are implied to amplify the local and
systemic low-grade inﬂammation associated with pancreatic
cancer. Most interestingly, we found the inﬂammatory response
mediator pentraxin 3 (PTX3), closely related to C-reactive protein
(CRP), to be almost 8-fold upregulated in TPSC versus NPSC.
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cancer migratory activity, and patient prognosis was reported [23].
Pancreatic cancer patients with high PTX3 levels had both signiﬁ-
cantly shorter progression free survival and shorter overall survival
compared to patients with low PTX3 levels. In addition, it was
suggested that PTX3 may be used as a promising biomarker in
pancreatic cancer prognosis. However, the biological and clinical
relevance of TPSC-derived PTX3 as well as the matrix and angiogen-
esis regulating factors reported herein on tumor progression,
remains to be elucidated.
Although genetic differences were not evaluated within the
present study, previous genome-wide proﬁling have identiﬁed
disease speciﬁc transcriptional ﬁngerprints between normal-,
pancreatitis- and pancreatic cancer-associated PSCs [24,25].
Together with the current proﬁling data reported herein, these
ﬁndings suggest that stellate cells of different activation stages
may acquire genetic or cellular adaptations which appear sus-
tained and inﬂuence their phenotype characteristics.
Interestingly, two insulin-like growth factor binding proteins
(IGFBP) were inversely expressed in NPSC and TPSC. IGFBP-2 was
46-fold more abundant, while IGFBP-3 was equally less abundant
in TPSC compared to NPSC. IGFBP-2 and IGFBP-3 are two major
regulators of the stability and bioavailability of IGF-I, a potent
mitogen for numerous tumor types including pancreatic cancer
[26,27]. High levels of IGF-I with concurrently low levels of IGFBP-
3 has been associated with increased risk of pancreatic cancer
[28]. IGFBP-2 can promote a maintained activation status of the
mitogenic IGF/PI3K pathway by negatively regulate PTEN abun-
dance [29]. The discordant IGFBP-2 and IGFBP-3 levels in TPSC
may thus in a paracrine fashion be involved in enhancing
pancreatic cancer cell growth by stabilizing IGF-I levels in the
local tumor area as well as enhancing the activity of IGF/PI3K
pathway. IGF-I has been demonstrated as an important mitogen
for liver myoﬁbroblasts [30]. IGF-I is also known to stimulate both
pancreatic cancer cell proliferation and motility [31]. Yet, to our
knowledge no studies of direct effects of IGF-I on human PSC have
been reported. Although an inverse expression of IGFBP-2 and
IGFBP-3, IGF-I was found in the present study to stimulate
proliferation of both NPSC and TPSC. In addition, our data indicate
for the ﬁrst time that the invasive capabilities of PSCs increased in
response to IGF-I. Interestingly, the IGF-I-stimulated motility was
signiﬁcantly higher in TPSC compared to NPSC. Recently, TPSCs
were shown to co-migrate with pancreatic cancer cells from the
primary site to the metastatic lesions, where they create a growth
permissive environment [32]. As IGF-I often is overexpressed by
tumor cells, this may contribute to facilitate PSC motility in a
paracrine fashion and thus inﬂuence the aggressiveness of the
disease [33]. In addition, it is plausible that the PSC-derived
IGFBPs may inﬂuence the tumor cells and PSCs both in an IGF-
dependent and independent manner in the local tumor micro-
environment [29,34].
A potential limitation of this study, as with many unique cell
lines, may be that the conditionally immortalized TPSC and NPSC
reported herein are generated from one individual. For future
perspectives it would be highly valuable to generate additional
PSC cell lines using the same temperature-sensitive conditionally
immortalization approach. With the well-known pancreatic
tumor heterogeneity, a broader panel of PSC cell lines would
allow for the comparison of inter-individual variations in PSC
cellular characteristics within a patient population, and providethe means of a more generalized understanding of their impact
on tumor behavior.
In summary, our study is the ﬁrst to report the generation of
conditionally immortalized human non-tumor and tumor-derived
pancreatic stellate cell lines, which will be important in studies of
the active stroma compartment associated with pancreatic cancer.
The discordant expression of the identiﬁed matrix-, angiogenesis-
, inﬂammatory- and growth regulating factors by TPSC and NPSC
may potentially be of clinical relevance and warrant further
investigation. A better understanding of the active stroma com-
partment is signiﬁcant to the identiﬁcation of novel therapeutic
opportunities and improved patient outcome.Acknowledgments
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